Skip to main content
. Author manuscript; available in PMC: 2019 Mar 25.
Published in final edited form as: Biochem Biophys Res Commun. 2018 Jun 15;503(2):684–690. doi: 10.1016/j.bbrc.2018.06.061

Fig. 3. Rosiglitazone Reduces Alveolar Macrophage Activation 20 days post MWCNT-Instillation.

Fig. 3.

Quantitative-PCR analysis of (A) CCL2 and (B) osteopontin expression in BAL cells of vehicle or MWCNT-instilled animals receiving normal chow or rosiglitazone (6 mg/kg). (C) Mean fluorescence intensity of nuclear NF-κB p65 protein in MWCNT-instilled animals receiving normal chow or rosiglitazone (6 mg/kg), ≤99 cells/animal. ★p < 0.01, n ≥ 5/treatment.